Viewing nowMemantine Tablets (Memantine Hydrochloride)
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

MFDS item code 201906092 · Approved 2019.08.27 · Insurance code 645906690
Treatment of moderate to severe Alzheimer’s disease
This medication is used for the treatment of moderate to severe Alzheimer's disease. Alzheimer's disease is a condition characterized by a gradual decline in memory and cognitive function, and this medication helps to slow the progression of symptoms and improve quality of life. It aids in mitigating cognitive decline and supports smoother daily living. With consistent use, it can effectively manage symptoms of Alzheimer's disease, making it a suitable therapeutic option for patients with moderate to severe Alzheimer’s disease.
This medication is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. This medication may be taken regardless of food intake. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (days 1-7) Administer 5mg once daily for 7 days. Week 2 (days 8-14) Administer 10mg once daily for 7 days. Week 3 (days 15-21) Administer 15mg once daily for 7 days. From week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Elderly patients: Based on clinical data, the recommended dose in elderly patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment: No dosage adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dosage adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medication.
This medication should not be used by patients who are allergic to its components. It is also not safe for patients with severely impaired liver function or very poor kidney function. Patients with epilepsy or a history of seizures, or those with a constitution prone to seizures, should use this medication with caution. Additionally, taking this medication with similar acting drugs such as amantadine, ketamine, or dextromethorphan can increase the risk of side effects and should be avoided. Patients with conditions that may change urine acidity must be monitored closely during use. The safety of this medication for patients with heart disease or uncontrolled hypertension has not been established, so caution is required. Patients using this drug may experience side effects such as dizziness, headache, constipation, drowsiness, and hypertension; if these symptoms worsen, consultation with a doctor is necessary. Rarely, symptoms of confusion, hallucination, and psychosis may occur, so any abnormal symptoms should be reported immediately. This medication may interact with other drugs, so it is essential to inform a doctor or pharmacist of any current medications. Women who are pregnant or may become pregnant must carefully consider the benefits and risks of using this medication, and nursing mothers are advised to discontinue breastfeeding. Its safety and efficacy have not been confirmed for children or adolescents under the age of 18, so it is recommended not to use it. In case of overdose, severe symptoms such as confusion, drowsiness, dizziness, and vomiting may occur, necessitating immediate visit to a medical facility; as there is no specific antidote, treatment will be provided according to symptoms. Patients using this medication should exercise caution when driving or operating machinery and keep it out of reach of children. Additionally, transferring the medication to another container may jeopardize its quality and safety and should be avoided.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a sealed container. Additionally, it is best to store the medication at room temperature, between 1 to 30 degrees Celsius, away from excessive heat or cold.
White, oblong film-coated tablets
100 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 10mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.